Register / Log in
Live Now

A faculty of global experts

The webcasts will bring together a faculty of global experts who have used GW CBD in the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).

Selim Benbadis

  • Prof. Dr.
  • USA
  • University of South Florida

Selim Benbadis is Professor of Neurology at the University of South Florida and is Director of the University of South Florida/Tampa General Hospital Comprehensive Epilepsy Program. He has authored more than 100 articles and book chapters and serves on several editorial boards.

Ulrich Brandl

  • Prof. Dr.
  • Germany
  • University Hospital Jena

Ulrich Brandl is Director of the Department of Neuropaediatrics, University Hospital Jena, Germany, where he also serves as Chairman of the Ethics Committee.

Richard FM Chin

  • Prof. Dr.
  • United Kingdom
  • Royal Hospital for Sick Children, Edinburgh

Richard Chin is Professor of Paediatric Neurology and Clinical Epidemiology, and the Director of the Muir Maxwell Epilepsy Centre, at The University of Edinburgh, UK. He is an Honorary Consultant Paediatric Neurologist at the Royal Hospital for Sick Children (Edinburgh).
 

Angela M Kaindl

  • Prof. Dr.
  • Germany
  • Charité – Universitätsmedizin Berlin

Angela Kaindl is Director of the Department of Pediatric Neurology and the Center for Chronically Sick Children at Charité – Universitätsmedizin Berlin. She is also Principal Investigator at the Charité Institute of Cell Biology and Neurobiology.

Andreas Schulze-Bonhage

  • Prof. Dr.
  • Germany
  • Epilepsy Center, University Hospital Freiburg

Andreas Schulze-Bonhage is Medical Director at the Freiburg Epilepsy Center, University of Freiburg, and President of the German Society of Epileptology. He is author of more than 340 peer-reviewed publications, has been active as a Principal Investigator in 40 multicentre clinical trials, and receives research funding from the EU, German Federal Ministry of Education and Research (BMBF), Deutsche Forschungsgemeinschaft, and the National Institutes of Health.

Bernhard Steinhoff

  • Prof. Dr.
  • Germany
  • University of Freiburg

Bernhard Steinhoff is Professor of Neurology and Clinical Neurophysiology at the University of Freiburg and is Medical Director of the Epilepsy Centre Kork. He is a past president of the German Society of Epileptology and author of numerous peer-reviewed papers and book articles.

Elizabeth Thiele

  • Prof. Dr.
  • USA
  • Massachusetts General Hospital

Elizabeth Thiele is Director of the Pediatric Epilepsy Service at Massachusetts General Hospital, Boston, MA, USA, and is Professor of Neurology at the Harvard Medical School. She organised and established the Herscot Center for Tuberous Sclerosis Complex and a ketogenic diet clinic to treat and manage patients with epilepsy.

Sameer M Zuberi

  • Prof. Dr.
  • United Kingdom
  • Royal Hospital for Children, Glasgow

Sameer Zuberi is Consultant Paediatric Neurologist at the Royal Hospital for Children and Honorary Professor of Paediatric Neurology in the University of Glasgow. He leads the Paediatric Neurosciences Research Group and is clinical lead of the Scottish National Genetic Epilepsy Service. His other roles include President of the European Paediatric Neurology Society, Editor-in-Chief of the European Journal of Paediatric Neurology, past Chair of the International League Against Epilepsy (ILAE) Commission on Classification & Terminology (2013-17) and ILAE Nosology & Definitions Task Force Member. 

Nick Jones

  • PhD
  • United Kingdom
  • GW Pharmaceuticals Ltd

Nick Jones is Director of Regulatory Affairs at GW Pharmaceuticals Ltd and has 13 years of cannabinoid experience, including a GW-funded PhD in the field of pharmacology elucidating the non-clinical anticonvulsant potential of CBD for the treatment of epilepsies. Nick transitioned to Global Regulatory Affairs after 8 years in the Preclinical Department at GW directing development programmes and overseeing operations.   




Faculty Disclosures

Selim Benbadis

  • Consultant for Brain Sentinel, Cavion, Ceribell, Eisai, Greenwich, LivaNova, NeuroPace, SK Biopharmaceuticals, Sunovion
  • Speakers’ bureau for Eisai, Greenwich, LivaNova, Sunovion
  • National Medical Director for RSC Diagnostic Services (EEG)
  • Florida Medical Director of Stratus/Alliance (EEG)
  • Member of Epilepsy Study Consortium
  • Grant support from Cavion, LivaNova, Greenwich, SK Biopharmaceuticals, Sunovion, Takeda, Xenon 
  • Royalties as an author or editor for eMedicine-Medscape-WebMD, UpToDate
  • Editorial board for Epilepsy.com (Epilepsy Foundation) controversy section, eMedicine-Medscape-WebMD, Epileptic Disorders, Epilepsy and Behavior, Expert Review of Neurotherapeutics

Ulrich Brandl

  • Honoraria for presentations, lectures, or advisory boards from Bial, Desitin, Eisai, GW Pharmaceuticals, UCB, Zogenix

Richard FM Chin

  • Honoraria for presentations, lectures, or advisory boards from GW Pharmaceuticals, Zogenix, Eisei
  • Local principal investigator in GW Pharmaceuticals and Zogenix sponsored clinical trials
  • GW Pharmaceuticals has provided Epidyolex® free of charge for patients on a named patient basis

Angela M Kaindl

  • Speaker honoraria from GW Pharmaceuticals

Andreas Schulze-Bonhage

  • Research support from Bial, BMBF, DFG, EU, HBP, NIH
  • Honoraria for lectures or advice from Arvelle, Bial, Eisai, GW Pharmaceuticals, UCB

Bernhard Steinhoff

  • Speaker honoraria from Al-Jazeera, Desitin, Eisai, GW Pharmaceuticals, Hikma, Novartis, Sandoz, UCB 
  • Advisory boards or consultancy agreements from Arvelle, Bial, B. Braun, Desitin, Eisai, GW Pharmaceuticals, UCB

Elizabeth Thiele

  • Consultant for GW Pharmaceuticals, Zogenix, Biocodex, Aquestive, West Therapeutics, RegenexBio
  • Research grants from  GW Pharmaceuticals, Zogenix

Sameer M Zuberi

  • Research funding from Epilepsy Research UK, Glasgow Childrens Hospital Charity, UCB Pharma, Dravet Syndrome UK, Ring Chromosome 20 Research & Support, Tenovus Foundation
  • Honoraria for advisory boards, educational activities and consultancy for GW Pharmaceuticals, Zogenix Ltd, Biocodex, Encoded Genomics, UCB Pharma, Nutricia
  • Principal investigator on behalf of his institution for commercial research trials for GW Pharmaceuticals and Zogenix Ltd

Nick Jones

Full-time employee of GW Pharmaceuticals

Login

Already registered?
Log in using your email address.

REGISTER

New to this platform?
Click below to register and to gain access to our on-demand videos and Epidyolex® (cannabidiol) shared experience webcasts.
Register now

Register for our Epidyolex®(cannabidiol) shared experience webcasts

Enter your details below to register. Did you already register? Click here to login.

Personal info *

Webcast info

Legal info

Next step

Thanks for registering

Thanks for registering. Please check your email to verify your account. If you don't receive this email shortly, please check your spam folder.

The email will contain further instructions.

Thanks for submitting a question

Thank you for submitting your question.

All questions will be collated and directed to the relevant speaker(s) for discussion in the live webcasts.
 

Welcome to the GW Pharmaceuticals Epilepsy Focus microsite!

This microsite is intended for UK healthcare professionals or German healthcare professional prescribers only.
Please confirm that you are a registered UK healthcare professional or German healthcare professional prescriber.





Welcome to GW Pharmaceuticals Epilepsy Focus microsite!

Thank you for visiting our microsite.

Please note that this microsite is only accessible to UK healthcare professionals and German healthcare professional prescribers.
For more information about GW Pharmaceuticals, please visit our corporate website.

 
 

You are about to leave this website

Please note this link will redirect you to an external website.

Please confirm if you are happy to continue.

Please note this link will redirect you to an external website.

Please confirm if you are happy to continue.

Continue Cancel
 
 

CONFIRM YOUR EMAIL ADDRESS

Thank you for completing this form. Please note that you are not yet fully registered. You will receive an email to your email address from noreply@epilepsy-focus.co.uk with a confirmation link. In order to complete the registration process and gain full access to our e-learning videos and webcasts, please click the link in your confirmation email.

If you do not receive a confirmation email, please check your spam folder. Also, please verify that you entered a valid email address in our sign-up form.

If you need assistance, please contact support-focus@gwpharm.com

I Understand
 
 

THANKS FOR SUBMITTING A QUESTION

Thank you for submitting your question.

All questions will be collated and directed to the relevant speaker(s) for discussion in the live webcasts.

Close
 
Please use a larger browser window for a better website experience.